This cholesterol drug promised to be a game-changer. Why did it flop in the clinic — and is there still hope?
Nature, Published online: 03 November 2026; doi:10.1038/d41586-026-03504-2 Physicians were excited about several therapies that slash levels of lipoprotein(a) — an important cardiovascular risk factor. One major trial failed to show a benefit, and now scientists are scrambling to work out what that means.
We haven't written up this one. Nature has the full story — the link below goes straight to it.
